LITHIUM- lithium bromatum liquid 
Marco Pharma International LLC.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Drug Facts

Active Ingredients

Lithium Bromatum 3xHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

For the temporary relief of symptoms due to depression, anxiety, and vertigo.

Keep out of reach of children.

Dosage

Adults: Take 20 drops on the toungue or in water two to three times daily. Children receive 1/2 of the adult amount.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

(Read Suggested Use Section)

Inactive Ingredients

Ethyl alcohol (18% by vol.) and water.

Lithium_N1S393_N1L393

LITHIUM 
lithium bromatum liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:60986-1019
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LITHIUM BROMIDE (UNII: 864G646I84) (LITHIUM CATION - UNII:8H8Z5UER66) LITHIUM BROMIDE3 [hp_X]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ALCOHOL (UNII: 3K9958V90M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:60986-1019-350 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product02/28/2018
2NDC:60986-1019-4100 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product02/28/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic03/01/1992
Labeler - Marco Pharma International LLC. (161994277)
Registrant - Marco Pharma International LLC. (161994277)
Establishment
NameAddressID/FEIBusiness Operations
Nestmann Pharma GmbH323426262manufacture(60986-1019)

Revised: 12/2021
Document Id: d2bf5b96-6ae5-93a3-e053-2995a90a7a34
Set id: f4a1d451-33ad-4df3-ae68-58cfbfccfa89
Version: 4
Effective Time: 20211209
 
Marco Pharma International LLC.